BioCentury
ARTICLE | Company News

Management tracks

November 8, 2016 12:55 AM UTC

Cancer company Neon Therapeutics Inc. (Cambridge, Mass.) named Richard Gaynor president of R&D. He was SVP of global product development and medical affairs in the oncology division at Eli Lilly and Co. (NYSE:LLY).

Rare disease company Mereo BioPharma Group Ltd. (LSE:MPH) named Richard Jones CFO. He was CFO at Shield Therapeutics plc (LSE:STX)...